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Introduction
PSH is common and, with few exceptions, resolves
spontaneously. In complicated cases treatment can be
difficult.
Case Report
Here we present an 11 year old Iranian girl, of healthy
parents suffered from chronic PSH with chronic
exanthema, severe ulcerative dermatitis and arthralgia.
Clinical observation: no fever, no arthritis, no signs of
polyserositis or hepatosplenomegaly; Laboratory: normal
values (full blood count, CRP, complement (C3, C4), no
autoantibodies (ANA, ANCA, anti-ds-DNA), no cryoglo-
bulins, zinc, IgG, IgM). Abnormal findings: highly ele-
vated IgA in serum (maximum 2030 mg/dl), elevation of
ESR and MRP8/ 14. Skin biopsy: leukocytoclastic infil-
trates in subcutaneous fatty tissue. Immunohistochemis-
try: IgA deposits in tip of papillae and upper corium. No
mutation in Marenostrin was found. Multimodal thera-
peutic approaches (Cortisone, Methotrexate, Azathiopr-
ine, Colchicine, i.v. Immunoglobulins) remained without
success for 8 years. With the administration of Dapsone
symptoms resolved within days and remain under control
for > 8 months now. Met-Hb level is tolerable.
Discussion
Anti-inflammatory potency of dapsone is illustrated. Thera-
peutic efficacy of Dapsone has been reported in chronic
PSH[1,2], but the mechanism remains to be fully eluci-
dated. Hypothesis: Endothelial cells and hyperreactive
B-cells (as illustrated by IgA elevation) secrete IL-8. IL-8 is
elevated in patients with PSH [3]. IL-8 stimulates perivascu-
lar invasion by neutrophils. Dapsone can inhibit secretion
of IL-8 [4], thereby impairing neutrophil function [5-7].
In conclusion Dapsone might be benefical for com-
plicated cases of PSH. The mechanism of its anti-
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